Christopher Michael Brede

Christopher Brede practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health.

Christopher Brede's NPI, 1093958621, was assigned on April 13, 2009. Christopher Brede graduated from University of Michigan Medical School in 2009. Christopher Brede holds Michigan license 4301106787.

Christopher Brede's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth, at 100 Michigan St NE, Grand Rapids, MI 49503 in Kent County. The practice phone is (616) 391-1774.

Christopher Brede's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health. Christopher Brede is also affiliated with Corewell Health Greenville Hospital. The medical group on file is Corewell Health Medical Group West. Dmand AI also links Christopher Brede to 2 more hospitals, 3 medical groups, 2 group practices and clinics and 2 rural health clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Brede practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Christopher Brede's primary specialty in the NPI Registry, under taxonomy code 208800000X. Christopher Brede is licensed in Michigan.

CMS data shows 147 Medicare services from Christopher Brede across 5 procedure codes in 2024, for 172 Medicare patients. Medicare paid $12,535 for them.

CMS counts 172 Medicare patients who saw Christopher Brede in 2026. The largest group is 65 to 74, with 92 patients. 74% of them have high cholesterol, and 73% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christopher Brede's median patient age at 70, with 27% women.

In 2026, Christopher Brede wrote 406 Medicare Part D claims for 134 patients. 93% of them were for generic drugs. CMS names the drug for 275 of them, across 5 drugs with 11 or more claims each, at $28,221 in total drug cost. In 2023, CMS named 345 claims across 8 drugs.

Christopher Brede accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christopher Brede as offering telehealth.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Christopher Brede, published from 2011 to 2023. 2015 was the busiest year, with 2. The most frequent topics are Prostatic Neoplasms, Prostatectomy and Carcinoma, Renal Cell. Christopher Brede has published most often in Urol Oncol. Christopher Brede's most frequent co-authors are Conrad Maxwell Tobert, MD, Nicholas Joseph Douville, MD and John E. Humphrey, MD.

Dmand AI links Christopher Brede to 1 clinical trial. Conditions studied include Non-Muscle Invasive Bladder Neoplasms and Urinary Bladder Neoplasms.

CMS Open Payments shows 40 general payments to Christopher Brede from 10 drug and device companies from 2016 to 2025. Education make up the largest share, 83% of the total. Intuitive Surgical, Inc. paid the most, $14,089.

Christopher Brede graduated from University of Michigan Medical School in 2009.